Evaluation of the stability of ceftazidime-avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy-A regulatory compliance study in accordance with the requireme (2022–2023)

Grant type:
Pfizer Inc Global Medical Grant
Researchers:
  • NHMRC Emerging Leadership Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    NHMRC Emerging Leadership Fellow
    Faculty of Medicine
    Affiliate Research Fellow of School
    School of Pharmacy
    Faculty of Health and Behavioural Sciences
Funded by:
Pfizer Inc